MicroRNA-181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib

MicroRNA-181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib

MicroRNA-181 (miR-181) has been recently demonstrated to participate in the differentiation and development of immune cells, including natural killer cells and B and T lymphocytes, and myeloid linages, including erythroid and megakaryocytic cells. The aberrant expression of miR-181, particularly low...

Full description

Bibliographic Details
Main Authors: WANG, GUANGYU, ZHAO, RAN, ZHAO, XINGSHENG, CHEN, XI, WANG, DONG, JIN, YINJI, LIU, XI, ZHAO, CI, ZHU, YUANYUAN, REN, CHENGCHENG, LI, MINGHUI, JIN, XIAOMING, ZHANG, FENGMIN, ZHONG, ZHAOHUA, WANG, TIANZHEN, LI, XIAOBO
Format: Online
Language:English
Published: D.A. Spandidos 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665220/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665220/

Similar Items